Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Highnoon LaboratoriesKAR:HINOON -0.45%96 Dividend Yield % is 5.20% as of Jul. 25, 2026, which is 75% above its 10-year median of 2.97. GuruFocus rates KAR:HINOON with a GF Score™ of 96/100 and a GF Value™ of ₨1,019.72 (Fairly Valued). The stock has 3 warning signs investors should review. Among 513 Drug Manufacturers companies, Highnoon Laboratories ranks better than 88.11% on this metric.
As of today (2026-07-25), the Trailing Annual Dividend Yield of Highnoon Laboratories is 5.20%.
Good Sign:
Highnoon Laboratories Ltd stock Dividend Yield % is close to 3-year high.
The historical rank and industry rank for Highnoon Laboratories's Dividend Yield % or its related term are showing as below:
KAR:HINOON'
s Dividend Yield % Range Over the Past 10 Years
Min: 1.01 Med: 2.97 Max: 6
Current: 5.2
During the past 13 years, the highest Dividend Yield of Highnoon Laboratories was 6.00%. The lowest was 1.01%. And the median was 2.97%.
KAR:HINOON's Dividend Yield % is ranked better than 88.11% of 513
companies
in the Drug Manufacturers industry
Industry Median: 1.97
vs KAR:HINOON: 5.20
During the past 12 months, Highnoon Laboratories's average Dividends Per Share Growth Rate was 33.30% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 40.70% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 40.00% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 30.50% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Highnoon Laboratories was 45.20% per year. The lowest was 22.00% per year. And the median was 32.40% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Highnoon Laboratories Dividend Yield % Related Terms
Highnoon Laboratories Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Highnoon Laboratories's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAR:HINOON vs LLY, JNJ, ABBV: Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, Highnoon Laboratories's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Highnoon Laboratories Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Highnoon Laboratories's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Highnoon Laboratories's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Highnoon Laboratories Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
PKR 50.000000
2026-04-22
2026-04-22
2026-05-15
Cash Dividend
annually
PKR:PKR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Highnoon Laboratories's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Highnoon Laboratories (KAR:HINOON) has a Dividend Yield % of 5.20% as of Jul. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Highnoon Laboratories and its competitors. This is 75% above median its historical median of 2.97. Over the past decade, Highnoon Laboratories' Dividend Yield % has ranged from 1.01 to 6.00. According to the industry distribution chart, Highnoon Laboratories ranks #61 out of 513 companies in the Drug Manufacturers industry, placing it in the top 11.9%.
Is Highnoon Laboratories' Dividend Yield % too high?
Highnoon Laboratories' current Dividend Yield % of 5.20% is 75% above median its 10-year median of 2.97. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 6.00. The Drug Manufacturers industry median Dividend Yield % is 1.97. Highnoon Laboratories' value of 5.20% is 164% above this industry median. Based on the distribution chart, Highnoon Laboratories ranks #61 out of 513 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Highnoon Laboratories has a GF Score™ of 96/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Highnoon Laboratories' Dividend Yield % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Highnoon Laboratories ranks #61 out of 513 companies for Dividend Yield %. This places Highnoon Laboratories in the top 12% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 1.97. Highnoon Laboratories' value of 5.20% is 164% above this benchmark. Historically, Highnoon Laboratories' own Dividend Yield % has ranged from 1.01 to 6.00 over the past decade. While the company's 10-year median is 2.97 vs. the industry median of 1.97, Highnoon Laboratories has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 1.97, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Highnoon Laboratories's current Dividend Yield % of 5.20% is 164% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Highnoon Laboratories and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 1.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Highnoon Laboratories's current Dividend Yield % is 5.20%, which is 75% above median its own 10-year median of 2.97. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Highnoon Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Highnoon Laboratories (KAR:HINOON) is currently considered Fairly Valued. The stock's GF Value™ is ₨1,019.72, compared to a current price of ₨961.21 — trading 5.7% below its estimated fair value. The current Dividend Yield % is 5.20%, which is 75% above median its 10-year median of 2.97 and 164% above the Drug Manufacturers industry median of 1.97. Highnoon Laboratories' overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Highnoon Laboratories (KAR:HINOON), the current Dividend Yield % is 5.20% as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Highnoon Laboratories (KAR:HINOON) Overvalued in 2026?
Based on GuruFocus' analysis, Highnoon Laboratories stock appears to be undervalued.
The current stock price of ₨961.21 is trading 5.7% below its estimated GF Value™ of ₨1,019.72.
GuruFocus considers Highnoon Laboratories to be Fairly Valued.
Key valuation signals for KAR:HINOON:
Dividend Yield %: 5.20% (75% above median its 10-year median of 2.97)
GF Value™: ₨1,019.72 vs. price of ₨961.21 (5.7% below fair value)
Industry Position: 164% above the Drug Manufacturers median (#61 of 513)
No single metric tells the full story. See the KAR:HINOON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Highnoon Laboratories Ltd is a company engaged in the manufacture, import, sale, and marketing of pharmaceutical and allied consumer products. It focuses on the alimentary tract and metabolism, antihistamines, anti-infectives, cardiovascular, endocrine, hematology, musculoskeletal, nervous system, parasitology, respiratory, and urinary. Its products include AIRTAL (Aceclofenac); ARIA (ketotifen); ARTECXCIN, and artrodar (diacerein). Its other products include Asthavent, AXESOME, Bezisox, Betatec, and many more.
96GF Score
Get the complete analysis for KAR:HINOON
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
KAR:HINOON has been successfully added to your 
